2.96
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché MRVI Giù?
Forum
Previsione
Precedente Chiudi:
$3.02
Aprire:
$3.02
Volume 24 ore:
1.39M
Relative Volume:
1.12
Capitalizzazione di mercato:
$429.27M
Reddito:
$288.95M
Utile/perdita netta:
$-119.03M
Rapporto P/E:
-3.2871
EPS:
-0.9005
Flusso di cassa netto:
$60.67M
1 W Prestazione:
-5.73%
1M Prestazione:
-26.37%
6M Prestazione:
+7.64%
1 anno Prestazione:
-28.16%
Maravai Lifesciences Holdings Inc Stock (MRVI) Company Profile
Nome
Maravai Lifesciences Holdings Inc
Settore
Industria
Telefono
(858) 546-0004
Indirizzo
10770 WATERIDGE CIRCLE SUITE 200, SAN DIEGO
Compare MRVI vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
MRVI
Maravai Lifesciences Holdings Inc
|
2.96 | 437.97M | 288.95M | -119.03M | 60.67M | -0.9005 |
|
VRTX
Vertex Pharmaceuticals Inc
|
491.47 | 117.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
803.17 | 82.85B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
821.96 | 51.58B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
314.40 | 40.75B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.07 | 38.33B | 4.98B | 69.60M | 525.67M | 0.5198 |
Maravai Lifesciences Holdings Inc Stock (MRVI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-26 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2024-12-19 | Iniziato | Guggenheim | Neutral |
| 2024-12-05 | Downgrade | Goldman | Neutral → Sell |
| 2024-11-14 | Iniziato | Wolfe Research | Peer Perform |
| 2024-11-08 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2024-08-28 | Iniziato | Wells Fargo | Overweight |
| 2024-08-13 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2024-04-10 | Iniziato | Craig Hallum | Buy |
| 2023-12-12 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2023-08-08 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-05-23 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2023-05-09 | Downgrade | Goldman | Buy → Neutral |
| 2023-01-05 | Downgrade | UBS | Buy → Neutral |
| 2022-12-14 | Iniziato | Deutsche Bank | Buy |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-11-03 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2020-12-16 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2020-12-15 | Iniziato | BofA Securities | Buy |
| 2020-12-15 | Iniziato | Credit Suisse | Outperform |
| 2020-12-15 | Iniziato | Goldman | Buy |
| 2020-12-15 | Iniziato | Jefferies | Buy |
| 2020-12-15 | Iniziato | Robert W. Baird | Outperform |
| 2020-12-15 | Iniziato | Stifel | Buy |
| 2020-12-15 | Iniziato | William Blair | Outperform |
| 2020-12-14 | Iniziato | UBS | Buy |
Mostra tutto
Maravai Lifesciences Holdings Inc Borsa (MRVI) Ultime notizie
Market Moves: Will REFI face regulatory challengesWeekly Investment Report & Safe Entry Momentum Stock Tips - baoquankhu1.vn
Options Flow: Will Cohen Company Inc face regulatory challengesQuarterly Trade Review & Smart Investment Allocation Tips - baoquankhu1.vn
Gainers Report: Is Maravai LifeSciences Holdings Incs ROE strong enough2025 Buyback Activity & Smart Swing Trading Techniques - baoquankhu1.vn
Maravai to Announce Q4 and Full Year 2025 Results - Intellectia AI
Maravai LifeSciences To Host Earnings Conference Call on Wednesday, February 25, 2026 - Yahoo Finance
What MACD trends signal for Maravai LifeSciences Holdings Inc. (MAR) stockQuarterly Trade Review & Reliable Breakout Stock Forecasts - mfd.ru
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Stockholders to Reach Out - ACCESS Newswire
Growth Report: Is Tourmaline Bio Inc a speculative investmentProduct Launch & AI Powered Market Entry Strategies - baoquankhu1.vn
Bronstein, Gewirtz & Grossman, LLC Is Investigating Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Stockholders to Connect - ACCESS Newswire
Maravai LifeSciences Target of Unusually High Options Trading (NASDAQ:MRVI) - Defense World
Volume Report: How does Maravai LifeSciences Holdings Inc score in quality rankings2025 Market WrapUp & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
Tejara Capital Ltd Has $7.04 Million Position in Maravai LifeSciences Holdings, Inc. $MRVI - MarketBeat
Stock Analysis: Is Amylyx Pharmaceuticals Inc stock a buy or sell2025 Technical Overview & Consistent Profit Alerts - baoquankhu1.vn
Maravai LifeSciences Holdings (MRVI): Investor Outlook Amidst A 14.54% Potential Upside - DirectorsTalk Interviews
Market Review: What are CERo Therapeutics Holdings Inc Equity Warrants earnings expectationsJuly 2025 Price Swings & Fast Moving Market Watchlists - baoquankhu1.vn
Aug Mood: Is Maravai LifeSciences Holdings Incs ROE strong enough2025 Valuation Update & Precise Trade Entry Recommendations - baoquankhu1.vn
Maravai LifeSciences Holdings (NASDAQ:MRVI shareholders incur further losses as stock declines 11% this week, taking five-year losses to 90% - simplywall.st
Maravai LifeSciences (NASDAQ:MRVI) Trading Down 8.9%What's Next? - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Shareholders to Connect - accessnewswire.com
Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT), Maravai Lifesciences Holdings (MRVI) and CVRx (CVRX) - The Globe and Mail
Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Maravai LifeSciences Sees Unusually Large Options Volume (NASDAQ:MRVI) - MarketBeat
MRVI SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno - The National Law Review
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Bear Alert: What is the dividend yield of Maravai LifeSciences Holdings IncRisk Management & Low Risk Growth Stock Ideas - baoquankhu1.vn
Aug Sentiment: Does China Liberal Education Holdings Limited offer margin of safetyJuly 2025 Final Week & Consistent Growth Equity Picks - baoquankhu1.vn
Will Maravai LifeSciences Holdings Inc. stock hit new highs in YEARPortfolio Value Summary & Advanced Technical Signal Analysis - bollywoodhelpline.com
Maravai LifeSciences Holdings, Inc. (MRVI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - accessnewswire.com
Maravai LifeSciences (NASDAQ:MRVI) Shares Down 5.8%Should You Sell? - MarketBeat
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Beha - GuruFocus
Maravai LifeSciences (NASDAQ:MRVI) & Capricor Therapeutics (NASDAQ:CAPR) Critical Review - Defense World
Maravai LifeSciences Holdings, Inc. (MRVI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Treasury Yields: Is Maravai LifeSciences Holdings Inc stock oversold or undervaluedRisk Management & Free Growth Oriented Trading Recommendations - Bộ Nội Vụ
Maravai LifeSciences Earnings Call: Mixed Signals - MSN
Maravai LifeSciences Holdings, Inc. (MRVI) Reports Q3 Loss, Misses Revenue Estimates - MSN
Can Maravai LifeSciences Holdings Inc. stock withstand economic slowdownWatch List & AI Optimized Trading Strategy Guides - ulpravda.ru
Maravai LifeSciences Holdings (MRVI) Stock Analysis: An Investor’s Guide to Navigating the Biotech Sector - DirectorsTalk Interviews
Why Maravai LifeSciences Holdings Inc. stock is in analyst buy zoneJuly 2025 Sentiment & Weekly High Conviction Ideas - Улправда
How MACOM Technology Solutions Holdings Inc. stock trades during market volatilityJuly 2025 Patterns & AI Enhanced Market Trend Forecasts - ulpravda.ru
Is Maravai LifeSciences Holdings Inc. stock oversold or undervaluedTrade Entry Report & Verified Momentum Stock Ideas - Улправда
Investors Purchase High Volume of Put Options on Maravai LifeSciences (NASDAQ:MRVI) - MarketBeat
Is Maravai LifeSciences Holdings Inc. stock resilient to inflationMACD Trading Signals & Rapid Portfolio Investment - Улправда
How Maravai LifeSciences Holdings Inc. (MAR) stock gains from tech spendingStock Watchlist Updates & Free Trading Psychology Coaching - Улправда
How buybacks impact Maravai LifeSciences Holdings Inc. stock valueEarnings Revision Updates & Identify Winning Stocks - Улправда
Volume Summary: Can Maravai LifeSciences Holdings Inc stock withstand economic slowdownJuly 2025 Analyst Calls & Consistent Profit Alerts - Bộ Nội Vụ
A US$75m Market Cap Boost Pleasing ToMaravai LifeSciences Holdings Insiders - simplywall.st
Maravai LifeSciences (NASDAQ:MRVI) Nasdaq Index Life Sciences Inputs - Kalkine Media
Net current asset value per share of Maravai Lifesciences Holdings, Inc. Class A – SWB:MAR - TradingView — Track All Markets
Maravai LifeSciences (NASDAQ:MRVI) Trading Up 11.3%Time to Buy? - MarketBeat
Ideas Watch: Is Maravai LifeSciences Holdings Inc. stock resilient to inflationMarket Volume Summary & Weekly Stock Performance Updates - Bộ Nội Vụ
Maravai Lifesciences Holdings Inc Azioni (MRVI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):